Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.75 |
| ▸ | PPARG | P37231 | 5/20 | 0.64 |
| ▸ | PPARD | Q03181 | 5/20 | 0.64 |
| ▸ | PPARA | Q07869 | 5/20 | 0.64 |
| ▸ | F7 | P08709 | 5/20 | 0.64 |
| ▸ | F3 | P13726 | 5/20 | 0.64 |
| ▸ | TERT | O14746 | 3/20 | 0.64 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.64 |
| ▸ | FABP4 | P15090 | 3/20 | 0.64 |
| ▸ | BLM | P54132 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.64 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.64 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.64 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.64 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2507620 | 1.00 | MAPT (0.75) | MAPTPPARGPPARDPPARAF7 | |
| SCHEMBL15287028 | 1.00 | MAPT (0.75) | MAPTPPARGPPARDPPARAF7 | |
| SCHEMBL15808604 | 1.00 | MAPT (0.75) | MAPTPPARGPPARDPPARAF7 | |
| SCHEMBL1593964 | 1.00 | MAPT (0.75) | MAPTPPARGPPARDPPARAF7 | |
| SCHEMBL3679458 | 1.00 | MAPT (0.75) | MAPTPPARGPPARDPPARAF7 | |
| SCHEMBL2228907 | 1.00 | MAPT (0.75) | MAPTPPARGPPARDPPARAF7 | |
| SCHEMBL3507735 | 1.00 | MAPT (0.75) | MAPTPPARGPPARDPPARAF7 | |
| SCHEMBL55116 | 1.00 | MAPT (0.75) | MAPTPPARGPPARDPPARAF7 | |
| SCHEMBL2228910 | 1.00 | MAPT (0.75) | MAPTPPARGPPARDPPARAF7 | |
| SCHEMBL267874 | 1.00 | MAPT (0.75) | MAPTPPARGPPARDPPARAF7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 594 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060246-A | Flame-retardant polypropylene composite material and preparation method and application thereof | 清远市普塞呋磷化学有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4687496-A1 | COMPOSITION COMPRISING OXYLIPINS PRESENT IN HUMAN MILK DERIVED SMALL EXTRACELLULAR VESICLES AND ITS USE IN THE PREVENTION AND TREATMENT OF INTESTINAL DISEASES | Fundación Para la Investigación del Hospital Universitario y Politécnico La Fe de la Comunidad Valenciana (ES) | 2026-02-11 | — | — | EP | claimed |
| US-12537071-B1 | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins | BERMUDES DAVID GORDON (US) | 2026-01-27 | — | — | US | claimed |
| US-20250319154-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2025-10-16 | — | — | US | claimed |
| US-20250216407-A1 | LIVER DISEASE TREATMENT AND ASSESSMENT USING OXYLIPINS | INIPHARM, INC. | 2025-07-03 | — | — | US | claimed |
| US-20250188135-A1 | A MULTIPLE ANTIGEN PRESENTING SYSTEM (MAPS)-BASED STAPHYLOCOCCUS AUREUS VACCINE COMPRISING B- AND T-CELL ANTIGENS, IMMUNOGENIC COMPOSITION, AND USES THEREOF | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-06-12 | — | — | US | claimed |
| WO-2025093740-A1 | RECOMBINANT PYOLYSIN PROTEIN | INTERVET INTERNATIONAL B.V. (NL) | 2025-05-08 | — | — | WO | claimed |
| WO-2025076477-A1 | STAPHYLOCOCCUS AUREUS VACCINE COMPOSITIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-04-10 | — | — | WO | claimed |
| US-12268734-B2 | Mycoplasma vaccines and uses thereof | UNIVERSITY OF SASKATCHEWAN (CA) | 2025-04-08 | — | — | US | claimed |
| WO-2025038756-A1 | BIOACTIVE COMPOUNDS WITH PESTICIDE ACTIVITIES DERIVED FROM AGED CULTURES OF GREEN MICROALGAE | TEXAS TECH UNIVERSITY SYSTEM (US) | 2025-02-20 | — | — | WO | claimed |
| US-20170266169-A1 | CYP2J2 ANTAGONISTS IN THE TREATMENT OF PAIN | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2017-09-21 | — | — | US | claimed |
| EP-3180028-A1 | CYP2J2 ANTAGONISTS IN THE TREATMENT OF PAIN | Fraunhofer-ges. zur Förderung der Angewandten Forschung E.V. (DE) | 2017-06-21 | — | — | EP | claimed |
| CN-106659789-A | Cyp2j2 antagonists in the treatment of pain | 弗劳恩霍夫应用研究促进协会 | 2017-05-10 | — | — | CN | claimed |
| US-20170008978-A1 | Family of Pain Producing Substances and Methods to Produce Novel Analgesic Drugs | UNIV TEXAS (US) | 2017-01-12 | — | — | US | claimed |
| WO-2016024015-A1 | CYP2J2 ANTAGONISTS IN THE TREATMENT OF PAIN | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2016-02-18 | — | — | WO | claimed |
| EP-2985036-A2 | CYP2J2 antagonists in the treatment of pain | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2016-02-17 | — | — | EP | claimed |
| US-20140308292-A1 | FAMILY OF PAIN PRODUCING SUBSTANCES AND METHODS TO PRODUCE NOVEL ANALGESIC DRUGS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-10-16 | — | — | US | claimed |
| US-20110311545-A1 | FAMILY OF PAIN PRODUCING SUBSTANCES AND METHODS TO PRODUCE NOVEL ANALGESIC DRUGS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2011-12-22 | — | — | US | claimed |
| EP-2381940-A2 | A NEW FAMILY OF PAIN PRODUCING SUBSTANCES AND METHODS TO PRODUCE NOVEL ANALGESIC DRUGS | Board of Regents, The University of Texas System (US) | 2011-11-02 | — | — | EP | claimed |
| WO-2010062900-A2 | A NEW FAMILY OF PAIN PRODUCING SUBSTANCES AND METHODS TO PRODUCE NOVEL ANALGESIC DRUGS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-06-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12537071-B1 | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins | ANTXR2, BCOR, ZFX | MAPT 3228/4885PPARG 2874/4885PPARD 2283/4885 |
| US-20110311545-A1 | FAMILY OF PAIN PRODUCING SUBSTANCES AND METHODS TO PRODUCE NOVEL ANALGESIC DRUGS | ALOX15B, ALOX5, ALOX15 | MAPT 3675/4885PPARG 532/4885PPARD 762/4885 |
| US-20170008978-A1 | Family of Pain Producing Substances and Methods to Produce Novel Analgesic Drugs | ALOX15B, ALOX5, ALOX15 | MAPT 3675/4885PPARG 532/4885PPARD 762/4885 |
| US-20140308292-A1 | FAMILY OF PAIN PRODUCING SUBSTANCES AND METHODS TO PRODUCE NOVEL ANALGESIC DRUGS | ALOX15B, ALOX5, ALOX15 | MAPT 3675/4885PPARG 532/4885PPARD 762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.